Delisting risk
ELAB · NASDAQ · Biotechnology

PMGC

Operates packaging and precision-machining businesses alongside early-stage technology programs.

$5.42
After-hours close+0.06 (+1.21%)
At close$5.36(−8.15%)
Loading prices…

Profile

PMGC Holdings Inc.ELABHealth Care

Sells custom protective packaging and high-tolerance contract machining through an acquisition-led diversified holding company that also owns preclinical bioscience and early-stage defense technology programs. Revenue comes from direct custom packaging sales and machining orders, repeat work, and referrals.

Combines custom protective packaging with precision engineering and machining, while also housing early-stage bioscience, defense-technology, and investment activities. Pacific Sun Packaging designs and manufactures electrostatic-discharge protective packaging for computer components. AGA Precision, SVM Machining, and A&B Aerospace provide high-tolerance CNC machining for aerospace, defense, and industrial customers. Operations and assets are principally in the United States, with manufacturing operations in California.

Generates operating revenue from customized packaging and contract machining, with repeat work, referrals, and customer purchase orders supporting the manufacturing businesses. NorthStrive Biosciences' muscle-preservation candidates remain preclinical, and NorthStrive Defense Tech's licensed autonomous-vehicle technology remains in prototype and simulation-validation stages. Recent acquisitions require integration, while revenue and purchases remain concentrated among a limited group of customers and suppliers.

Company facts

CEOGraydon Bensler
ListedNov 21, 2023
ExchangeNASDAQ
HeadquartersNewport Beach, CA
CountryUnited States
Employees34
CIK0001840563
ISINUS73017P5089

Key statistics

Market cap$2.4M
EPS (ttm)−$1,815.30
P/E (ttm)−0.0029
ROE-118.1%
P/B0.1547
P/S0.9356
Dividend yield
Beta3.97vs XLV 0.55

Year to date −99.6% · Average volume (30d) 64.2K

Analysts

No analyst consensus on record.

Earnings

EPS

Estimate
Reported−$6.10

Revenue

Estimate
Reported$1.3M

History

Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseNext session
Aug 14, 2026Q2 FY26−$6.10$1.3M+1.45%
May 14, 2026Q1 FY26−$11.21$682.0K+0.97%
Mar 26, 2026Q4 FY25−$0.52$304.1K−10.70%
Nov 14, 2025Q3 FY25−$19.80$285.9K−1.70%
View details

Financial highlights

12 quartersQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$0$0$285.9K$304.1K$682.0K$1.3M
Gross profit−$15.4K−$20$42.7K$47.5K$71.0K$104.5K
Operating income−$1.2M−$1.0M−$2.2M−$3.0M−$3.3M−$3.8M
Net income−$1.6M−$562.4K−$2.6M−$3.0M−$5.0M−$2.9M
Diluted EPS−$2,480.50−$379.20−$1,178.40−$519.20−$111.70−$6.00
Gross margin14.9%15.6%10.4%8.0%
Operating margin-767.5%-975.3%-487.0%-292.2%

Fiscal years (4-quarter sums)FY22 $766.3K · FY23 $1.7M · FY24 −$605.5K · FY25 $590.1K

Balance sheet, Jun 30, 2026Cash & short-term investments $18.8M · Total debt $13.9M · Total assets $36.6M · Shareholders' equity $16.7M

Dividends

No dividends on record.

Ownership

Institutions 1.43%6.5K sharesInsiders 0.26%1.2K sharesOther 98.31%446.7K shares

Shares outstanding 454.4K · Float 409.0K · 90.0% free float

A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.

Insider tradesForm 4

No open-market trades in the last 12 months.

View details

Peers

  • Ducommun

    Aerospace and defense manufacturing rival for complex components.

  • Howmet Aerospace

    Scaled aerospace components and fasteners contest machining awards.

  • UFP Technologies

    Custom ESD protective packaging overlaps electronics-component shipping.

  • Biohaven

    Advanced myostatin-activin therapy targets fat loss and lean-mass gains.

  • Scholar Rock

    Anti-myostatin programs challenge the muscle-health therapeutic thesis.

  • Novo Nordisk (ADR)

    Wegovy and Ozempic dominate the GLP-1 obesity-treatment ecosystem.

CompareAfter-hours close

CompanyPriceChange
PMGC$5.42+1.21%$2.4M0.9
Ducommun$176.300.00%$2.66B36.13.1+11.0%
Howmet Aerospace$265.80+0.39%$105.97B57.145.511.6+24.1%
UFP Technologies$300.05−0.05%$2.32B32.429.73.7+15.1%
Biohaven$15.16−1.56%$2.32B
Scholar Rock$57.800.00%$6.93B
Novo Nordisk (ADR)$45.60+0.00%$202.54B11.218.44.0+0.0%
Median32.432.93.8+13.0%